References
- Chiu CH, Waddingdon M, Greenberg D, et al. Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan. Emerg Infect Dis 2000;6:481–6
- Douvoyiannis M, Kalyoussef S, Philip G, et al. Chryseobacterium indologenes bacteremia in an infant. Int J Infect Dis 2010;14:e531–2
- Ceyhan M, Yildirim I, Tekeli A, et al. A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients. Am J Infect Control 2008;36:453–7
- Gungor S, Ozen M, Akinci A, et al. A Chryseobacterium meningosepticum outbreak in a neonatal ward. Infect Control Hosp Epidemiol 2003;24:613–17
- Leclercq R, Canton R, Brown DF, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2013;19:141–60
- Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 2004;17:638–80
- Gonzales-Marin C, Spratt DA, Millar MR, et al. Identification of bacteria and potential sources in neonates at risk of infection delivered by Caesarean and vaginal birth. J Med Microbiol 2012;61:31–41
- Bellais S, Naas T, Nordmann P. Molecular and biochemical characterization of Ambler class A extended-spectrum beta-lactamase CGA-1 from Chryseobacterium gleum. Antimicrob Agents Chemother 2002;46:966–70
- Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother 1997;41:2738–41
- Kirby JT, Sader HS, Walsh TR, et al. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997–2001). J Clin Microbiol 2004;42:445–8